Jazz Pharmaceuticals JAZZ Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's total current assets?
- Jazz Pharmaceuticals (JAZZ) reported total current assets of $4.58B in Q1 2026.
- How has Jazz Pharmaceuticals's total current assets changed year-over-year?
- Jazz Pharmaceuticals's total current assets increased by 11.0% year-over-year, from $4.13B to $4.58B.
- What is the long-term trend for Jazz Pharmaceuticals's total current assets?
- Over 5 years (2020 to 2025), Jazz Pharmaceuticals's total current assets has grown at a 8.0% compound annual growth rate (CAGR), from $2.84B to $4.17B.
- What does total current assets mean?
- The total value of all company assets that can be turned into cash within one year.
- How do you interpret total current assets?
- An increase generally indicates improved short-term liquidity, whereas a decrease may signal tightening working capital.
- How does total current assets compare across companies?
- Used to calculate the current ratio; standard benchmark for assessing short-term solvency across all industries.